Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis.

Saved in:
Bibliographic Details
Title: Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis.
Authors: Peng JX; Department of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Wang LZ; Department of Anesthesia, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Wang QT; Department of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Li HL; Department of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., Lin LJ; Department of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China., He JM; Department of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2024 Aug 22; Vol. 15, pp. 1393861. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-9812
DOI:10.3389/fphar.2024.1393861